Active Ingredient History
There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Colitis, Ulcerative (approved 1955)
Dermatitis (approved 2006)
Gastrointestinal Diseases (approved 1987)
Renal Insufficiency (approved 2012)
Acne Vulgaris (Phase 2)
Anemia, Sickle Cell (Phase 3)
Antioxidants (Phase 4)
beta-Thalassemia (Phase 3)
Child Nutrition Disorders (Phase 4)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 4)
Diarrhea (Phase 3)
Dysgeusia (Phase 3)
Enterocolitis, Necrotizing (Phase 4)
Gingival Diseases (Phase 3)
Hepatitis, Alcoholic (Phase 2)
Hepatolenticular Degeneration (Phase 3)
Hospitalization (Phase 3)
Hyaline Membrane Disease (Phase 4)
Infertility, Male (Phase 4)
Lichen Planus, Oral (Phase 4)
Malnutrition ()
Mucositis (Phase 3)
Respiratory Tract Infections (Phase 2)
Semen Analysis (Phase 4)
Serum (Phase 3)
Severe Acute Respiratory Syndrome (Phase 2)
Thalassemia (Phase 1)
Tuberculosis (Phase 1)
Zinc (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue